01 · The Goal

Reset aged cells toward a younger, healthier state

The goal is cellular rejuvenation — restoring aged cells toward a younger, more functional state without erasing what makes each cell what it is. If cells could be reset to repair and function the way they did years earlier, much of age-related decline could be addressed at its source rather than managed downstream.

02 · Why It Matters

Aging is written into cells: their gene-expression patterns drift, their ability to repair fades, and damaged “senescent” cells accumulate and inflame surrounding tissue. Most medicine treats the consequences — the failing organ, the stiff vessel. Cellular rejuvenation aims one level deeper, at the cell itself, so the body regains its own capacity to maintain and repair.

03 · What We’re Trying to Achieve

We are building the capability to rejuvenate cells safely and selectively — clearing harmful senescent cells, restoring youthful gene-expression patterns through partial reprogramming, and renewing the stem cells that maintain tissue. The honest boundary is large: most of this is demonstrated in cells and animals, and human use is frontier, pursued with strict safety because resetting cells carries real risks.

04 · How It Works

How it works

Clear senescent cells Demonstrated

Senolytic approaches remove damaged, inflammation-driving cells; demonstrated in animals and in early human trials.

Partial reprogramming Frontier

Briefly activating reprogramming factors restores youthful gene expression in animal tissue without erasing cell identity — frontier.

Renew stem-cell pools Demonstrated

Restoring the stem cells that maintain blood, muscle, and other tissues is advancing in research.

Protect against side effects Frontier

Doing all of this without raising cancer risk is the central safety problem, addressed in the laboratory now.

05 · Who’s Building It

Cited as evidence the capability is real — not as partners or endorsers.

Government & programs

National Institute on Aging (NIA, NIH) · NIH cell-biology and regenerative programs. Public research established the biology of senescence and reprogramming.

Universities & institutes

Salk Institute (cellular reprogramming) · Buck Institute · academic stem-cell and aging laboratories. Academic labs first showed aged cells can be partially reset.

Enabling science base

epigenetic reprogramming · senescence biology · stem-cell science · gene-expression control. — the established disciplines this capability is built upon.

06 · Technologies

The technologies: partial epigenetic reprogramming (transient reprogramming factors), senolytic and senomorphic agents, stem-cell renewal approaches, and the delivery and safety controls needed to apply them to specific tissues without harm.

07 · Breakthroughs

Reprogramming without identity loss Frontier

Animal studies show cells can be made biologically younger while staying the same cell type.

Senolytics in trials Demonstrated

Drugs that clear senescent cells have entered early human trials for age-related conditions.

Vision and tissue recovery Frontier

Reprogramming restored function in animal models of nerve and tissue damage — frontier.

Safety frameworks forming Frontier

Researchers are defining how to reprogram briefly and locally to avoid tumor risk.

08 · Remaining Challenges

The honest challenges: partial reprogramming is not a human therapy — it is demonstrated mainly in animals, and the cancer-risk and control problems are unsolved. Senolytics are promising but unproven for broad use. This is one of the most exciting and most overhyped areas in biology; we show only what is real, at the stage it has actually reached.

09 · Mature Capability

The future, fully built

Aged tissue can be safely renewed at the cellular level — senescent cells cleared, youthful function restored, repair capacity rebuilt — addressing age-related decline at its biological root, only ever within strict, proven safety limits.

Honest boundary: each item is tagged for where it stands — demonstrated, clinical, or frontier. The science is real, funded, and advancing, but this capability is not finished. AI supports human clinicians; it never replaces them.
10 · Evidence Vault

The proof, for this capability

Cited as evidence the capability is real, not as partners or endorsers.

Clinical anchor

Managing the downstream effects of cellular aging is established care. Stage: Clinical.

Demonstrated clearance

Senolytic clearance of senescent cells is demonstrated in animals and early trials. Stage: Demonstrated.

Frontier reprogramming

Partial reprogramming rejuvenates animal tissue in the lab. Stage: Frontier.

Honest framing

Real organizations are cited as evidence the capability is real — not as partners or endorsers. Human cellular rejuvenation is not available; nothing here is offered as a treatment.

Help build this future

Every signature grows the movement to make safe cellular rejuvenation real — and free at the point of need.

Paid for by Michael Floyd for President.

Scroll to Top